(Q46723719)

English

Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center

scientific article published on 18 October 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

author name string

Elizabeth M Grainger

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

H Sunny Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

J Paul Monk

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Stanley A Lemeshow

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Michael Gong

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Robert R Bahnson

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Steven K Clinton

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

publication date

18 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

26

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

125-132

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

The Prostate Cancer Prevention Trial: design, status, and promise

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

The influence of finasteride on the development of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Inorganic selenium retards progression of experimental hormone refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Residential sunlight exposure is associated with a decreased risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Diet and cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Statin drugs and risk of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Correlates of vitamin supplement use in the United States: data from the California Teachers Study cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Collection of food and dietary supplement intake data: What We Eat in America-NHANES.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

VITamins And Lifestyle Cohort Study: Study Design and Characteristics of Supplement Users

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Tomatoes or lycopene: a role in prostate carcinogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Intake of carotenoids and retinol in relation to risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.016

7 January 2021

Identifiers

10.1016/J.UROLONC.2007.01.016

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18312929

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46723719&oldid=2128434462"